Weiyi Fang

7PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 06, 2023
Progresses in biomarkers for cancer immunotherapy.

Xuwen Lin, Chenyu Zong, Zhihan Zhang

|Sep 26, 2023
FGFR families: biological functions and therapeutic interventions in tumors.

Qing Liu, Jiyu Huang, Weiwei Yan

|Nov 30, 2022
ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9-induced deubiquitination of β-catenin to block gastric cancer metastasis.

Jiahao Liu, Zhan Liu, Weiwei Yan

|Apr 17, 2020
Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.

Xian Lin, Ai-Min Li, Yong-Hao Li

|Nov 23, 2019
Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9.

YongHao Li, Xiong Liu, Xian Lin

|May 25, 2019
VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.

Yiyu Chen, Zhen Liu, Huijun Wang

Pageof 2

Frequent Collaborators

1 joint publications

Lijing Wang